Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
durvalumab
×
Clear all
Filters
2
NCT03528694
2025-11-25
POTOMAC
AstraZeneca
Phase 3
Active not recruiting
1,018 enrolled
NCT03317158
2025-01-30
ADAPT-BLADDER
Hoosier Cancer Research Network
Phase 1/2
Recruiting
55 enrolled
NCT04106115
2024-12-04
DURANCE
University College, London
Phase 1/2
Recruiting
64 enrolled